CD8A and neoplasm: In preclinical assays, IMCnyeso was found to induce cytokine production and dose-dependent tumor cell lysis by CD8+ effector T cells in co-cultures with antigen-positive tumor cell lines but not in co-cultures with antigen-negative tumor cells or healthy tissue cells.